Kapstone Financial Advisors LLC Buys 1,300 Shares of Abrdn Life Sciences Investors (NYSE:HQL)

Kapstone Financial Advisors LLC raised its stake in Abrdn Life Sciences Investors (NYSE:HQL) by 11.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 13,123 shares of the company’s stock after acquiring an additional 1,300 shares during the period. Kapstone Financial Advisors LLC’s holdings in Abrdn Life Sciences Investors were worth $185,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of HQL. Absolute Investment Advisers LLC bought a new stake in shares of Abrdn Life Sciences Investors during the fourth quarter worth $5,242,000. Sanctuary Advisors LLC grew its holdings in shares of Abrdn Life Sciences Investors by 11.4% during the third quarter. Sanctuary Advisors LLC now owns 13,256 shares of the company’s stock worth $183,000 after purchasing an additional 1,355 shares during the last quarter. Penserra Capital Management LLC bought a new stake in shares of Abrdn Life Sciences Investors during the third quarter worth $11,702,000. International Assets Investment Management LLC bought a new stake in shares of Abrdn Life Sciences Investors during the third quarter worth $204,000. Finally, Wolverine Asset Management LLC bought a new stake in shares of Abrdn Life Sciences Investors during the fourth quarter worth $1,594,000. 32.21% of the stock is currently owned by institutional investors.

Insider Activity at Abrdn Life Sciences Investors

In related news, major shareholder Saba Capital Management, L.P. sold 36,536 shares of the firm’s stock in a transaction dated Wednesday, February 12th. The stock was sold at an average price of $13.75, for a total value of $502,370.00. Following the transaction, the insider now owns 3,276,181 shares in the company, valued at $45,047,488.75. This trade represents a 1.10 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders have sold a total of 108,386 shares of company stock worth $1,511,590 over the last 90 days. Insiders own 10.06% of the company’s stock.

Abrdn Life Sciences Investors Stock Performance

Shares of HQL stock opened at $13.25 on Tuesday. The stock’s fifty day moving average is $13.73 and its 200-day moving average is $14.41. Abrdn Life Sciences Investors has a 52 week low of $12.76 and a 52 week high of $15.90.

Abrdn Life Sciences Investors Cuts Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Friday, February 21st will be issued a dividend of $0.47 per share. This represents a $1.88 annualized dividend and a dividend yield of 14.19%. The ex-dividend date of this dividend is Friday, February 21st.

Abrdn Life Sciences Investors Company Profile

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.